Xtant Medical Holdings, Inc. (XTNT)
AMEX · Common · CUSIP 98420P308
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for XTNT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
98420P308 (prev. 05644R101 )
Market Cap
Micro Cap
Previous Symbol
BONE (changed 10/19/2015)
Previous Name
Bacterin International Holdings, Inc.
Business: Xtant Medical Holdings, Inc. develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets.

Company Contact

CEO
Sean Browne
CFO
Scott Neils
Headquarters
664 Cruiser Lane, Belgrade, MT 59714
Phone
406-388-0480 · Toll-Free 888-886-9354
Investor Relations
David Carey, Lazar FINN · 212-867-1762 · david.carey@finnpartners.com
General Email
cs@xtantmedical.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »